Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Summary

The study has consists of two parts, a dose escalation part (Part 1) and a dose selection optimization part (Part 2). The primary objectives of this study are to evaluate the safety and tolerability of ISM3412 in participants with locally advanced/metastatic solid tumors, and to determine the RP2D of ISM3412.

Timeline

Start

2025-04-25

Primary completion

2028-03-31

Completion

2029-03-31

Drugs

Indications